NetScientific PLC NetScientific hosts Capital Markets Day (0709B)
14 Junho 2016 - 3:01AM
UK Regulatory
TIDMNSCI
RNS Number : 0709B
NetScientific PLC
14 June 2016
14 June 2016
NetScientific plc
("NetScientific" or the "Group")
NetScientific hosts Capital Markets Day to outline its strategy
and showcase its portfolio of assets
London, UK - 14 June 2016 - NetScientific plc (AIM: NSCI), the
transatlantic healthcare technology group, is today hosting a
Capital Markets Day in London to outline the comprehensive strategy
for the company and provide further detail on its portfolio
companies and their path to value creation.
Netscientific has undergone a transformation, with a
rationalisation of its portfolio and restructuring of the
management team, resulting in a streamlined group focused on
holding majority positions and delivery and maximising shareholder
value from its investments in digital health, diagnostics and
therapeutics.
At the event in London today, the Company's Chairman, Sir
Richard Sykes, and Chief Executive, Francois Martelet, will outline
the next steps for NetScientific in maximising value from its
portfolio companies. Representatives of the companies will also
provide a detailed overview of the companies, the changing
landscape in digital health, diagnostics and therapeutics, and
their respective strategies for value realisation. The Capital
Markets Day will be held at 85 Gresham Street, London EC2V 7NQ,
from 12pm until 5pm. The event will conclude with a question and
answer session and networking. Presentations from the Capital
Markets Day will be made available via the Company's website after
the event.
Sir Richard Sykes, Chairman of NetScientific, said:
"NetScientific's management team and portfolio focus have been
totally revitalised under the leadership of Francois Martelet. We
now have a focused portfolio of assets which are close to
commercialisation and which offer the scope for significant value
creation. We look forward to highlighting the key jewels in our
crown, and to explaining how they offer opportunities both to
provide patient benefit and shareholder value."
Presenters at the Netscientific Capital Markets Day will
include:
-- Sir Richard Sykes Chairman, Netscientific
-- Francois Martelet CEO, Netscientific
-- Gene Walther CEO, Vortex Biosciences
-- Steve Curd CEO, Wanda
-- Larry Cohen CEO, Glycotest
-- Frank K Bedu Addo CEO, PDS Biotechnology
-- Dr David Ribeiro CEO, ProAxsis
- Ends -
For more information, please contact:
NetScientific Tel: +44 (0)20 3514 1800
François R. Martelet,
M.D., CEO
Ian Postlethwaite, CFO
Investec (NOMAD and Tel: +44 (0)20 7597 4000
broker)
Gary Clarence / Daniel
Adams
Consilium Strategic Tel: +44 (0)20 3709 5700
Communications netscientific@consilium-comms.com
Mary-Jane Elliott /
Chris Gardner / Jessica
Hodgson / Chris Welsh
/ Laura Thornton
About NetScientific
NetScientific is a transatlantic healthcare technology group
with an investment strategy focused on sourcing, funding and
commercialising technologies that significantly improve the health
and well-being of people with chronic diseases. For more
information, please visit the website at www.netscientific.net.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCDBGDLSDBBGLX
(END) Dow Jones Newswires
June 14, 2016 02:01 ET (06:01 GMT)
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024